Categories Earnings, Technology

CenturyLink (CTL) reports inline earnings for Q4; tops revenue estimates

CenturyLink’s (NYSE: CTL) Q4 2019 earnings were inline with the market’s expectations while revenue surpassed the Street’s estimates. The company reported adjusted EPS of $0.33 on revenue of $5.57 billion. Analysts had projected CenturyLink to post earnings of $0.33 per share on revenue of $5.55 billion. CTL shares reached a new yearly high ($15:30) in today’s regular trading session and were down about 3% during the after-market session.

CenturyLink (CTL) Q4 2019 earnings infograph

On a GAAP basis, earnings per share was $0.21 for the fourth quarter of 2019, compared to a loss of $2.26 per share in the fourth quarter 2018.

FY20 Outlook

Commenting on the 2020 outlook, CFO Neel Dev said, “In 2019, we met all of our key financial outlook measures, highlighted by adjusted EBITDA growth and margin expansion. Our investments and initiatives position us well for 2020, and we expect full year adjusted EBITDA of $9.0 to $9.2 billion, capital expenditures of $3.6 to $3.9 billion and free cash flow of $3.1 to $3.4 billion.”

Other Updates

On January 31, the Monroe, LA based telecom company announced that it had completed an extension and repricing of its senior secured credit facilities originally entered into in June 2017.

In January, CenturyLink secured a task order, worth up to $1.6 billion, to provide secure network services and IT modernization solutions to the U.S. Department of the Interior (DOI). This order covers two areas and has a combined maximum value of $1.6 billion, with 11 one-year options that run through 2032.

CenturyLink stock had gained 2% in the past three months and 4% from this time last year.

We’re on Apple News! Follow us to receive the latest stock market, earnings, and financial news at your fingertips

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top